Food and Drugs Administration

Gastrointenstinal Drugs Advisory Committee

June 26, 2003




The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

Introduction, Dr. Francois Martin, MD, Axcan Pharma, Inc. (HTM) (PPT)

Photofrin® PDT for High-Grade Dysplasia in Barrett's Esophagus, Dr. Edvardas Kaminskas, MD, & Dr. Milton Fan, PhD, FDA (HTM) (PPT)